Drugs Pharma

Moderna in $35 million licensing deal with CytomX

Moderna, a US-based biotechnology company, announced a $35 million licensing deal with cancer-focused drugmaker CytomX to develop messenger RNA therapies.

Read More
Drugs Pharma

Amgen to buy Dublin-based Horizon for $27.8 billion

Amgen Inc, one of the world's largest biotechnology companies, will acquire Dublin-based Horizon Therapeutics Plc for $27.8 billion.

Read More